Olowe Olugbenga Adekunle, Mabayoje Victor Olatunji, Akanbi Olusola, Adefioye Olusolabomi Jose, Olowe Rita Ayanbolade, Fadeni Emmanuel Kehinde, Oluremi Adeolu Sunday, Opaleye Oluyinka Oladele
a Department of Medical Microbiology and Parasitology , College of Health Sciences , Osogbo , Nigeria.
b Department of Hematology and Blood Transfusion , College of Health Sciences , Osogbo , Nigeria.
Pathog Glob Health. 2016 Jun-Jul;110(4-5):205-8. doi: 10.1080/20477724.2016.1205311. Epub 2016 Jul 7.
Efforts to curb the spread of HIV transmission through transfusion of blood and its products is still a problem because of challenge in countries using antibody-based rapid methods to detect infection during window period. Transmission of HIV through infected blood and its products accounts for approximately 10% in African region.
This study analyzed true negativity of HIV infection in blood donors screened by ELISA test based on p24 core antigen detection. Four hundred and eighty (480) blood donors initially negative for HIV antibody by rapid screening kit, Determine™ HIV-1/2 (Abbott Laboratory, IL, USA) and re-screened with Immuno Comb® II HIV 1 and 2 (Bispot kit PBS Organics and Israel 2005). The samples were further tested for the presence of HIV antibody and p24 HIV core antigen using ELISA kits (Genscreen TM ULTRA HIV Ag-Ab) following manufacturer's instructions. All donors initially tested negative for Hepatitis B virus, Hepatitis C virus.
Two (0.42%) of 480 blood donors tested positive for the p24 HIV core antigen. The two positive donors for the p24 antigen had multiple sexual partners and recent sexually transmitted infections.
The association of the HIV p24 antigen with blood donation was highly significant (p = 0.000) and pose a great risk to recipients if screening of blood donor is only carried out by HIV antibody detection.
由于在窗口期使用基于抗体的快速方法检测感染的国家面临挑战,遏制通过输血及其制品传播艾滋病毒的努力仍然是一个问题。在非洲地区,通过受感染的血液及其制品传播艾滋病毒的情况约占10%。
本研究分析了基于p24核心抗原检测的酶联免疫吸附测定(ELISA)试验筛查的献血者中艾滋病毒感染的真阴性情况。480名献血者最初通过快速筛查试剂盒Determine™ HIV-1/2(美国伊利诺伊州雅培实验室)检测艾滋病毒抗体呈阴性,并使用Immuno Comb® II HIV 1和2(双斑点试剂盒PBS Organics和以色列,2005年)进行重新筛查。按照制造商的说明,使用ELISA试剂盒(Genscreen TM ULTRA HIV Ag-Ab)对样本进一步检测艾滋病毒抗体和p24艾滋病毒核心抗原的存在情况。所有献血者最初检测乙肝病毒、丙肝病毒均为阴性。
480名献血者中有2名(0.42%)p24艾滋病毒核心抗原检测呈阳性。这两名p24抗原阳性的献血者有多个性伴侣且近期有性传播感染。
艾滋病毒p24抗原与献血之间的关联非常显著(p = 0.000),如果仅通过艾滋病毒抗体检测对献血者进行筛查,会给受血者带来很大风险。